Rationale -Study reproducibility is valuable for validating or refuting results. Provision of reproducibility indicators, such as materials, protocols, and raw data in a study to improve its potential for reproduction. Efforts to reproduce noteworthy studies in the biomedical sciences have resulted in an overwhelming majority of them being found to be unreplicable, causing concern for the integrity of research in other fields, including medical specialities.
Introduction
Reproducibility-the ability to duplicate a study's results using the same materials and methods as the original investigator-is central to the scientific method (1) . Study reproducibility establishes confidence in the efficacy of therapies, while results that contradict original findings may lead to overturning previous standards. Herrera-Perez et al. recently evaluated 396 medical reversals in which suboptimal clinical practices were overturned when randomized controlled trials yielded results contrary to current practices (2) . Given the evolving nature of evidence-based patient care, studies must be conducted in a way that fosters reproducibility and transparency. Further, materials, protocols, analysis scripts, and patient data must be made available to enable verification.
Efforts supporting reproducibility are becoming more widespread owing to the open science movement. In 2013, the Center for Open Science was established to "increase the openness, integrity, and reproducibility of scientific research" (3) . The center sponsored two large-scale reproducibility efforts: a series of 100 replication attempts in psychology and a series of 50 landmark cancer biology study replication attempts. In the first, investigators successfully reproduced only 39% of the original study findings (4) . In the second, efforts were halted after only 18 replications because of lack of information and materials from authors, insufficient funding, and insufficient time to perform all the experiments (5) . The center also created the Open Science Framework, a repository in which authors may deposit study protocols, participant data, analysis scripts, and other materials needed for study reproduction. More recently, the center created Transparency and Openness Promotion Guidelines, which include eight transparency standards and provides guidance for funders and journals, and initiated the use of badges for journals that adopt reproducible practices.
Current estimates of study reproducibility are alarming. In the biomedical sciences, reproducibility rates may be as low as 25% (6) . One survey of 1576 scientists found that 90% of respondents believed science was experiencing a reproducibility crisis; 70% reported not being able to reproduce another investigator's findings, and more than half reported an inability to reproduce their own findings (7) . The picture is even less clear in the clinical sciences. Ioannidis found that of 49 highly cited original research publications, seven were refuted by newer studies, and seven suggested higher efficacy than follow-up results; only 22 were successfully replicated (8) . The National Institutes of Health and the National Science Foundation have responded to this crisis by taking measures to ensure that studies funded by tax dollars are more reproducible. However, little is known about the extent to which reproducibility practices are used in clinical research.
In this study, we evaluated reproducible and transparent research practices in the pulmonology literature (9) . Our goals were (i) to determine areas of strength and weakness in current use of reproducible and transparent research practices and (ii) to establish a baseline for subsequent investigations of the pulmonology literature.
Methods
This observational study employed a cross-sectional design. We used the methodology of Hardwicke et al. (9) , with modifications. In reporting this study, we follow the guidelines for meta-epidemiological methodology research (10) and the Preferred Reporting Items for Systematic Reviews and Meta-analyses (PRISMA) (11) . This study did not satisfy the regulatory definition for human subjects research as specified in the Code of Federal Regulations and therefore was not subject to institutional review board oversight. We have listed our protocol, materials, and data on Open Science Framework ( https://osf.io/n4yh5/ ).
Journal and Publication Selection
The National Library of Medicine catalog was searched by DT using the subject terms tag "Pulmonary Medicine[ST]" to identify pulmonary medicine journals on May 29, 2019. To meet inclusion criteria, journals had to be published in English and be MEDLINE indexed. We obtained the electronic ISSN (or linking ISSN) for each journal in the NLM catalog meeting inclusion criteria. Using these ISSNs, we formulated a search string and searched PubMed on May 31, 2019, to locate publications published between January 1, 2014, to December 31, 2018.
We then randomly selected 300 publications for data extraction using Excel's random number function ( https://osf.io/zxjd9/ ).
Extraction Training
Prior to data extraction, two investigators (JN, CS) underwent training to ensure inter-rater reliability. The training included an in-person session to review the study design, protocol, Google form, and location of the extracted data elements in two publications. The investigators were next provided with three additional publications from which to extract data. Afterward, the pair reconciled differences by discussion. This training session was recorded and deposited online for reference ( https://osf.io/tf7nw/ ). Prior to extracting data from all 300 publications, the two investigators extracted data from the first 10, followed by a final consensus meeting. Data extraction for the remaining 290 publications followed, and a final consensus meeting was held to resolve disagreements. A third author (DT) was available for adjudication, if necessary.
Data Extraction
The two investigators extracted data from the 300 publications in a duplicate and blinded fashion. A pilot-tested Google form was created from Hardwicke et al. (9) , with additions (see Table 1 for a description of the indicators of reproducibility and transparency). This form prompted coders to identify whether a study had important information that needed to be reproducible ( https://osf.io/3nfa5/ ). The extracted data varied by study design. Studies without empirical data (e.g., editorials, commentaries [without reanalysis], simulations, news, reviews, and poems) had only the publication characteristics, conflict of interest statement, financial disclosure statement, funding sources, and open access availability. We catalogued the most recent year and 5-year impact factor of the publishing journals. We also included the following study designs: cohort, case series, secondary analysis, chart review, and cross-sectional. Finally, we expanded the funding options to include university, hospital, public, private/industry, or nonprofit.
Verification of Open Access Status of Publications
We used Open Access Button (http://www.openaccessbutton.org) to identify publications as being publicly available. Both the journal title and DOI were used in the search to mitigate chances of missing an article. If Open Access Button could not locate an article, we searched Google and PubMed to confirm open access status.
Publication Citations Included in Research Synthesis and Replication
For empirical studies, Web of Science was used to identify whether the publication was replicated in other studies and had been included in systematic reviews and/or meta-analyses. To accomplish these tasks, two investigators (CS, JN) inspected the titles, abstracts, and introductions of all publications in which the reference study was cited. This process was conducted in a duplicate, blinded fashion.
Data Analysis
We used Microsoft Excel to calculate descriptive statistics and 95% confidence intervals (95% CIs).
Results

Study Selection and Article Accessibility
Our PubMed search identified 299,255 publications. Limiting our search to articles published from January 1, 2014, to December 31, 2018, yielded 72,579 publications, from which 300 were randomly selected. Of these 300 publications, 194 were open access and 106 were behind a paywall. Eight publications could not be accessed by investigators and were thus excluded, leaving 292 for further analysis (Figure 1 ). Characteristics of the included publications can be found in Table 2 . Figure 2 depicts an overview of our study results. A total of 150 empirical studies (excluding 30 case studies/case series and two meta-analyses) were evaluated for material availability. The majority of studies offered no statement regarding availability of materials ( n = 133; 88.67%
Availability of Reproducibility Indicators
[95% CI, 85.08%-92.25%]). Sixteen studies (10.67% [7.17%-14.16%]) had a clear statement regarding the availability of study materials. One study (0.67% [0%-1.59%]) included an explicit statement that the materials were not publicly available. Ten of the 16 materials files were accessible; the remaining four either led to a broken URL link or a pay-walled request form.
A total of 152 empirical studies (excluding 30 case studies/case series) were assessed for availability of protocols, raw data, and analysis scripts. Two studies provided access to a protocol (1.32% [0.03%-2.61%]). Data availability statements were more common, with 31 studies (20.39% [15.84%-24.95%]) including a statement that at least partial data were available.
Analysis scripts were not found in a single study. More information on these metrics is presented in Supplemental Table 1 .
Study Preregistration
A total of 152 empirical studies (excluding 30 case studies/case series) were searched for a statement regarding study preregistration. Few studies included statements: 14 (9.21% [5.94%-12.48%]) declared preregistration, while three (1.97% [0.40%-3.55%]) explicitly disclosed that they were not pre-registered. More information on preregistration is presented in Supplemental Table 1 .
Study Replication and Citation Analysis
Of 152 empirical studies analyzed, only one (0.66% [0%-1.57%]) reported replication of the methods of a previously published study. No studies were cited by a replication study. A total of 180 of the 182 empirical studies (excluding two meta-analyses) were evaluated to determine whether any had been included in a systematic review. Thirteen studies (7.22% [4.29%-10.15%]) were cited once in a systematic review or meta-analysis, 11 studies (6.11% [3.40%-8.82%]) were cited in two to five systematic reviews or meta-analyses, and one study (0.56% [0%-1.40%]) was cited in more than five systematic reviews or meta-analyses. One study (0.56% [0.55%-0.55%]) was explicitly excluded from a systematic review.
Conflict of Interest and Funding Disclosures
All 292 publications were assessed for their inclusion of a conflict of interest statement and/or a funding statement. A majority ( n = 207; 70.89%) included a conflict of interest statement, with 157 declaring no competing interests (53.77% [48.13%-59.41%]). More than half of the publications failed to provide a funding statement ( n = 164; 56.16%; Table 3 ). In publications with a funding statement, public funding was the most common source ( n = 37; 12.67%).
Discussion
In this cross-sectional review of pulmonology publications, a substantial majority failed to provide materials, participant data, or analysis scripts. Many were not preregistered and few had an available protocol. Reproducibility has been viewed as an increasingly troublesome area of study methodology (12) . Recent attempts at reproducing preclinical (13, 14) and clinical studies have found that only 25%-61% of studies may be successfully reproduced (6, 15) . Many factors contribute to limited study reproducibility, including poor (or limited) reporting of study methodology, prevalence of exaggerated statements, and limited training on experimental design in higher education (16) . In an effort to limit printed pages and increase readability, journals may request that authors abridge methods sections (17) . Here, we briefly comment on selected indicators to present a balanced view of the perspectives of those in favor of reproducibility and transparency and those who resist enacting such changes.
First, data sharing allows for the independent verification of study results or reuse of that data for subsequent analyses. Two sets of principles exist. The first, known as FAIR, outlines mechanisms for findability, accessibility, interoperability, and reusability. FAIR principles are intended to apply to study data as well as the algorithms, tools, and workflows that led to the data. FAIR advocates that data be accessible to the right people, in the right way, and at the right time (18) . A second set of principles relate to making data available to the public for access, use, and share without licenses, copyrights, or patents (19) . While we advocate for data sharing, we recognize that it is a complex issue. First, the process for making data available for others' use requires skills. Further, the process, which includes the construction of data dictionaries and data curation, is time consuming. Furthermore, concerns exist with regard to unrestricted access to data facilitating a culture of "research parasites," a term coined by Drazen and Longo (20) that suggests that secondary researchers might exploit primary research data for publication. Drazen and Longo also cautioned that secondary authors might not understand the decisions made when defining parameters of the original investigations. Finally, the sensitive nature of some data causes concern among researchers. Other research stakeholders must be involved as well. Although many journals recommend the use of reporting guidelines for various study designs, such as CONSORT and PRISMA, evidence suggests that these guidelines are not followed by authors or enforced by journals (33) . When journals enforce adherence to reporting guidelines, the completeness of reporting is improved (34) . Detractors of reporting guidelines are concerned that certain checklists (CONSTORT, STROBE, STARD) will be used to judge research quality rather than improve writing clarity, that editors and peer reviewers will fail to enforce these guidelines, and that insufficient research exists to evaluate the outcomes from applying these guidelines (35) .
Our study has both strengths and limitations. We randomly sampled a large number of pulmonology journals containing various types of publications to generalize our findings across the specialty. Our study design also used rigorous training sessions and a standardized protocol to increase the reliability of our results. In particular, our data extraction process, which involved blinded and duplicate extraction by two investigators, is the gold standard systematic review methodology and is recommended by the Cochrane Collaboration (36) . We have made all study materials available for public review to enhance the reproducibility of this study. Regarding Publicly accessible study protocol
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